Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Lilly describes novel compounds for postmenopausal syndrome and related conditions

March 18, 1998

ARL-15849KF: a selective CCK-A agonist for the treatment of eating disorders

March 18, 1998

Spironolactone and Diane 35 may have synergistic effects in hirsutism

March 18, 1998

FDA advisory committee reaches a stand-off on orlistat recommendation

March 16, 1998

More antiobesity proteins emerge from Lilly research

March 16, 1998

Gene therapies for obesity revealed by Merck & Co., Baylor College of Medicine

March 16, 1998

The association between neuropathy and microcirculation in diabetic foot ulcers

March 16, 1998

Lilly enters genomics alliance for type II diabetes and obesity research

March 13, 1998

INVICORP shows 70% efficacy in ED study

March 13, 1998

FDA approves low-dose Estratab for osteoporosis

March 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...